﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Thu, 16 Apr 2026 02:04:39 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/July-2024/rss/1935</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/July-2024/rss/1935" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Trending Topics in Health-System Pharmacy]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-in-health-system-pharmacy-1</link><description><![CDATA[ Is β-blocker use at discharge associated with an increased risk in patients with COPD following acute myocardial infarction? 

   

 Although β-blockers are associated with decreased mortality ...]]></description><pubDate>Sun, 07 Jul 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-in-health-system-pharmacy-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2350]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Researchers evaluate diagnostic practices for heparin-induced thrombocytopenia]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/researchers-evaluate-diagnostic-practices-for-heparin-induced-thrombocytopenia</link><description><![CDATA[  Aiya Almogaber, PharmD  

   

   

 Researchers assessed the diagnostic accuracy of commonly recommended tests and algorithms for heparin-induced thrombocytopenia (HIT), a severe and ...]]></description><pubDate>Sun, 07 Jul 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/researchers-evaluate-diagnostic-practices-for-heparin-induced-thrombocytopenia</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2351]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Agency updates HIV recommendations for injectable cabotegravir and rilpivirine use]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/agency-updates-hiv-recommendations-for-injectable-cabotegravir-and-rilpivirine-use</link><description><![CDATA[  Olivia C. Welter, PharmD  

   

 In March 2024, the International Antiviral Society–USA (IAS-USA) guidelines panel issued a letter to  JAMA  to provide an updated HIV treatment recommendation ...]]></description><pubDate>Sun, 07 Jul 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/agency-updates-hiv-recommendations-for-injectable-cabotegravir-and-rilpivirine-use</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2352]]></dc:identifier></item><item><dc:creator><![CDATA[Michelle Powell]]></dc:creator><title><![CDATA[Hospitals slow to use newer gram-negative antibiotics]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/hospitals-slow-to-use-newer-gram-negative-antibiotics</link><description><![CDATA[  Terri D’Arrigo  

 FDA approved seven next-generation gram-negative antibiotics between 2014 and 2019. Yet a study published in the May 2024 issue of the  Annals of Internal Medicine  found that ...]]></description><pubDate>Sun, 07 Jul 2024 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/hospitals-slow-to-use-newer-gram-negative-antibiotics</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2353]]></dc:identifier></item></channel></rss>